Kisspeptin-10 Dosage Guide
Complete guide to Kisspeptin-10 dosing protocols, administration methods, and safety considerations for research purposes.
Research Use Only: The dosage information provided is for educational and research purposes. Peptides are not approved by the FDA for human use. Always consult with a healthcare professional.
Recommended Dosage
Research protocols vary widely. Studies have used IV boluses of 1-10mcg/kg or subcutaneous administration. Clinical applications still being developed.
Administration Method
IV or subcutaneous injection. Has very short half-life requiring frequent administration or continuous infusion for sustained effects.
Side Effects to Monitor
Limited data. May cause flushing, increased heart rate, and changes in libido. Generally well-tolerated in studies.
Safety Considerations & Risks
Research stage peptide. May cause unpredictable hormonal effects. Not suitable for those with hormone-sensitive conditions.